Log In
BCIQ
Print this Print this
 

MatBA

  Manage Alerts
Collapse Summary General Information
Company Cancer Genetics Inc.
DescriptionMature B cell neoplasm microarray-based comparative genomic hybridization test
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics: Personal genomics testing
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsDiagnosis, prognosis and patient risk stratification of diffuse large B cell lymphoma (DLBCL); Diagnosis, prognosis and patient risk stratification of follicular lymphoma; Diagnosis, prognosis and patient risk stratification of mantle cell lymphoma (MCL)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today